Kala Bio Inc (KALA)
7.07
+0.36
(+5.32%)
USD |
NASDAQ |
May 10, 16:00
7.07
0.00 (0.00%)
After-Hours: 18:58
Kala Bio Price: 7.07 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 6.925 | 6.925 | 6.713 | 6.713 | 693.00 |
| May 08, 2024 | 6.84 | 7.300 | 6.800 | 7.08 | 2394.00 |
| May 07, 2024 | 7.03 | 7.17 | 6.736 | 6.92 | 17499.00 |
| May 06, 2024 | 6.99 | 7.025 | 6.69 | 6.94 | 10729.00 |
| May 03, 2024 | 6.83 | 7.007 | 6.78 | 7.007 | 4531.00 |
| May 02, 2024 | 6.719 | 7.03 | 6.70 | 6.755 | 8114.00 |
| May 01, 2024 | 6.62 | 7.09 | 6.62 | 6.81 | 8694.00 |
| Apr 30, 2024 | 6.84 | 6.85 | 6.735 | 6.82 | 1596.00 |
| Apr 29, 2024 | 6.35 | 6.98 | 6.35 | 6.85 | 10191.00 |
| Apr 26, 2024 | 6.32 | 6.540 | 6.24 | 6.30 | 5721.00 |
| Apr 25, 2024 | 6.704 | 6.770 | 6.18 | 6.18 | 8260.00 |
| Apr 24, 2024 | 6.48 | 6.51 | 6.40 | 6.40 | 1101.00 |
| Apr 23, 2024 | 6.26 | 6.675 | 6.219 | 6.566 | 5284.00 |
| Apr 22, 2024 | 6.47 | 6.47 | 6.15 | 6.33 | 12630.00 |
| Apr 19, 2024 | 6.83 | 6.83 | 6.430 | 6.59 | 8535.00 |
| Apr 18, 2024 | 6.90 | 6.90 | 6.66 | 6.81 | 9250.00 |
| Apr 17, 2024 | 6.84 | 6.99 | 6.65 | 6.838 | 14764.00 |
| Apr 16, 2024 | 7.14 | 7.20 | 6.85 | 6.85 | 17867.00 |
| Apr 15, 2024 | 7.25 | 7.25 | 7.00 | 7.00 | 23989.00 |
| Apr 12, 2024 | 7.25 | 7.30 | 7.20 | 7.20 | 16054.00 |
| Apr 11, 2024 | 7.34 | 7.61 | 7.20 | 7.20 | 18705.00 |
| Apr 10, 2024 | 7.300 | 7.489 | 7.21 | 7.35 | 20847.00 |
| Apr 09, 2024 | 7.600 | 7.700 | 7.40 | 7.41 | 18333.00 |
| Apr 08, 2024 | 7.56 | 7.80 | 7.56 | 7.62 | 5619.00 |
| Apr 05, 2024 | 7.60 | 7.98 | 7.60 | 7.60 | 13146.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.67
Minimum
Dec 22 2022
689.50
Maximum
Jun 02 2020
173.32
Average
95.25
Median
Price Benchmarks
| CEL-SCI Corp | 1.42 |
| AIM ImmunoTech Inc | 0.4033 |
| IGC Pharma Inc | 0.5104 |
| NovaBay Pharmaceuticals Inc | 0.0804 |
| Protalix BioTherapeutics Inc | 1.11 |
Price Related Metrics
| PS Ratio | 2.990 |
| Price to Book Value | 2.654 |
| Earnings Yield | -253.7% |
| Market Cap | 19.91M |